SEATTLE, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the prevention and treatment of ...
Dyne Therapeutics Inc.-5.60% $1.56B ...
After hours: 7:59:47 pm GMT-5 ...
After hours: 7:20:28 p.m. EST ...
Pre-Market: 4:34:56 a.m. EST ...
Pre-market: 5:40:11 am GMT-5 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback